Literature DB >> 34431065

Myocardial scar reduction after cardiac resynchronization therapy assessed by gated myocardial perfusion SPECT.

Naoya Matsumoto1, Yasuyuki Suzuki2, Yasuo Okumura3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34431065     DOI： 10.1007/s12350-021-02787-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   3.872


× No keyword cloud information.
  12 in total

1.  Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?

Authors:  Maureen M Henneman; Ji Chen; Petra Dibbets-Schneider; Marcel P Stokkel; Gabe B Bleeker; Claudia Ypenburg; Ernst E van der Wall; Martin J Schalij; Ernest V Garcia; Jeroen J Bax
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

Review 2.  Myocardial perfusion single photon emission computed tomography for the assessment of mechanical dyssynchrony.

Authors:  Mark M Boogers; Ji Chen; Jeroen J Bax
Journal:  Curr Opin Cardiol       Date:  2008-09       Impact factor: 2.161

3.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Paulus Kirchhof; Carina Blomstrom-Lundqvist; Luigi P Badano; Farid Aliyev; Dietmar Bänsch; Helmut Baumgartner; Walid Bsata; Peter Buser; Philippe Charron; Jean-Claude Daubert; Dan Dobreanu; Svein Faerestrand; David Hasdai; Arno W Hoes; Jean-Yves Le Heuzey; Hercules Mavrakis; Theresa McDonagh; Jose Luis Merino; Mostapha M Nawar; Jens Cosedis Nielsen; Burkert Pieske; Lidija Poposka; Frank Ruschitzka; Michal Tendera; Isabelle C Van Gelder; Carol M Wilson
Journal:  Eur Heart J       Date:  2013-06-24       Impact factor: 29.983

4.  Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony.

Authors:  Ji Chen; Ernest V Garcia; Russell D Folks; C David Cooke; Tracy L Faber; E Lindsey Tauxe; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

5.  Novel algorithm for quantitative assessment of left ventricular dyssynchrony with ECG-gated myocardial perfusion SPECT: useful technique for management of cardiac resynchronization therapy.

Authors:  Keisuke Kiso; Akira Imoto; Yoshihiro Nishimura; Hideaki Kanzaki; Takashi Noda; Shiro Kamakura; Yoshio Ishida
Journal:  Ann Nucl Med       Date:  2011-08-13       Impact factor: 2.668

6.  Prognostic value of poststress left ventricular volume and ejection fraction by gated myocardial perfusion SPECT in women and men: gender-related differences in normal limits and outcomes.

Authors:  Tali Sharir; Xingping Kang; Guido Germano; Jeroen J Bax; Leslee J Shaw; Heidi Gransar; Ishac Cohen; Sean W Hayes; John D Friedman; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

7.  Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Authors:  Leslee J Shaw; Manuel D Cerqueira; Maria M Brooks; Andrew D Althouse; Veronica V Sansing; George A Beller; Rodica Pop-Busui; Raymond Taillefer; Bernard R Chaitman; Raymond J Gibbons; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-04-19       Impact factor: 5.952

8.  Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy.

Authors:  Christopher Uebleis; Stefan Hellweger; Rüdiger Paul Laubender; Alexander Becker; Hae-Young Sohn; Sebastian Lehner; Alexander Haug; Peter Bartenstein; Paul Cumming; Serge D Van Kriekinge; Piotr J Slomka; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-03       Impact factor: 9.236

9.  Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy.

Authors:  Mark M Boogers; Serge D Van Kriekinge; Maureen M Henneman; Claudia Ypenburg; Rutger J Van Bommel; Eric Boersma; Petra Dibbets-Schneider; Marcel P Stokkel; Martin J Schalij; Daniel S Berman; Guido Germano; Jeroen J Bax
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

10.  Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT Registry.

Authors:  Keiichiro Kuronuma; Robert J H Miller; Yuka Otaki; Serge D Van Kriekinge; Marcio A Diniz; Tali Sharir; Lien-Hsin Hu; Heidi Gransar; Joanna X Liang; Tejas Parekh; Paul B Kavanagh; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Balaji K Tamarappoo; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  Circ Cardiovasc Imaging       Date:  2021-07-20       Impact factor: 7.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.